Skip to main content
SpringerLink
Log in

Apoptosis, clearance mechanisms, and the development of systemic lupus erythematosus

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Cell death by apoptosis is an integral part of many biologic processes, including embryonic development, T- and B-cell selection, the elimination of potentially autoreactive lymphocytes in the periphery, and maintenance of lymphocyte homeostasis through activation-induced cell death. There is also increasing evidence that apoptosis may maintain immune tolerance and that it may be the process that generates the self antigens responsible for the initial development of autoimmunity. This review discusses some of the biochemical steps involved in the apoptotic process, how potentially immunogenic self antigens are generated during apoptosis, and the mechanisms by which the products of apoptosis are cleared and processed to avoid breaking immune tolerance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Hengartner MO: The biochemistry of apoptosis. Nature 2000, 407:770–776.

    Article  PubMed  CAS  Google Scholar 

  2. Krammer PH: CD95’s deadly mission in the immune system. Nature 2000, 407:789–795.

    Article  PubMed  CAS  Google Scholar 

  3. Utz PJ, Anderson P: Life and death decisions: regulation of apoptosis by proteolysis of signaling molecules. Cell Death Differ 2000, 7:589–602.

    Article  PubMed  CAS  Google Scholar 

  4. Thornberry NA, Lazebnik Y: Caspases: enemies within. Science 1998, 281:1312–1316.

    Article  PubMed  CAS  Google Scholar 

  5. Salvesen GS, Dixit VM: Caspase activation: the induced-proximity model. Proc Natl Acad Sci U S A 1999, 96:10964–10967.

    Article  PubMed  CAS  Google Scholar 

  6. Kischkel FC, Hellbardt S, Behrmann I, et al.: Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 1995, 14:5579–5588.

    PubMed  CAS  Google Scholar 

  7. Chinnaiyan AM, O’Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995, 81:505–512.

    Article  PubMed  CAS  Google Scholar 

  8. Scaffidi C, Fulda S, Srinivasan A, et al.: Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998, 17:1675–1687.

    Article  PubMed  CAS  Google Scholar 

  9. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998, 94:481–490.

    Article  PubMed  CAS  Google Scholar 

  10. Li H, Zhu H, Xu C, Yuan J: Cleavage of BID by Caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998, 94:491–501.

    Article  PubMed  CAS  Google Scholar 

  11. Susin S, Lorenzo HK, Zamzami N, et al.: Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med 1999, 189:381–394.

    Article  PubMed  CAS  Google Scholar 

  12. Krajewski S, Krajewska M, Ellerby LM, et al.: Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischaemia. Proc Natl Acad Sci U S A 1999, 96:5752–5759.

    Article  PubMed  CAS  Google Scholar 

  13. Stennicke HR, Deveraux QL, Humke EW, et al.: Caspase-9 can be activated without proteolytic processing. J Biol Chem 1999, 274:8359–8362.

    Article  PubMed  CAS  Google Scholar 

  14. Rodriguez J, Lazebnik Y: Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev 1999, 13:3179–3184.

    Article  PubMed  CAS  Google Scholar 

  15. Kerr J, Wyllie A, Currie A: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972:239–257.

  16. Rudel T, Bokoch G: Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 1997, 276:1571–1574.

    Article  PubMed  CAS  Google Scholar 

  17. Song Q, Lees-Miller S, Kuma S, et al.: DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis. EMBO J 1996, 15:32238–3246.

    Google Scholar 

  18. Van Parijs L, Abbas AK: Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998, 280:243–248.

    Article  PubMed  Google Scholar 

  19. Navratil JS, Ahearn JM: Apoptosis and autoimmunity: complement deficiency and systemic lupus erythematosus revisited. Curr Rheumatol Rep 2000, 2:32–38.

    PubMed  CAS  Google Scholar 

  20. Nagata S: Fas ligand-induced apoptosis. Annu Rev Genet 1999, 33:29–55.

    Article  PubMed  CAS  Google Scholar 

  21. Froelich JC, Orth K, Turbov J, et al.: New paradigm for lym phocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis. J Biol Chem 1996, 271:29073–29079.

    Article  PubMed  CAS  Google Scholar 

  22. Medema JP, Toes REM, Scaffidi C, et al.: Cleavage of FLICE (caspase-8) by granzyme B during cytotoxic T lymphocyteinduced apoptosis. Eur J Immunol 1997, 27:3492–3498.

    Article  PubMed  CAS  Google Scholar 

  23. Casciola-Rosen LA, Anhalt G, Rosen A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994, 179:1317–1330.

    Article  PubMed  CAS  Google Scholar 

  24. Zhuang L, Wang B, Shinder GA, et al.: TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation. J Immunol 1999, 162:1440–1447.

    PubMed  CAS  Google Scholar 

  25. Caricchio R, Reap EA, Cohen PL: Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis. J Immunol 1998, 161:241–251.

    PubMed  CAS  Google Scholar 

  26. Rich T, Allen RL, Wyllie AH: Defying death after DNA damage. Nature 2000, 407:777–783.

    Article  PubMed  CAS  Google Scholar 

  27. Miranda ME, Tseng C, Rashbaum W, et al.: Accessibility of SSA/ Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes. J Immunol 1998, 161:5061–5069. These researchers demonstrate that the autoantigens Ro and La become accessible to autoantibodies in blebs on the surface of apoptotic cardiac myocytes. These findings confirm that autoantigens become redistributed as a result of apoptosis, and suggest that autoantibodies may be directly responsible for tissue injury.

    PubMed  CAS  Google Scholar 

  28. Casciola-Rosen L, Rosen A, Petri M, Schlissel M: Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci U S A 1996, 93:1624–1629.

    Article  PubMed  CAS  Google Scholar 

  29. Price BE, Rauch J, Shia MA, et al.: Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a b2-glycoprotein I-dependent manner. J Immunol 1996, 157:2201–2208.

    PubMed  CAS  Google Scholar 

  30. Nava VE, Rosen A, Veluiona MA, et al.: Sindbis virus induces apoptosis through a caspase-dependent, CrmA-sensitive pathway. J Virol 1998, 72:452–459.

    PubMed  CAS  Google Scholar 

  31. Rosen A, Casciola-Rosen L, Ahearn J: Novel packages of viral and self-antigens are generated during apoptosis. J Exp Med 1995, 181:1557–1561.

    Article  PubMed  CAS  Google Scholar 

  32. Casciola-Rosen LA, Miller DK, Anhalt GJ, Rosen A: Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucloeprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem 1994, 269:30757–30760.

    PubMed  CAS  Google Scholar 

  33. Casciola-Rosen LA, Anhalt GJ, Rosen A: DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 1995, 182:1625–1634.

    Article  PubMed  CAS  Google Scholar 

  34. Casciola-Rosen L, Nicholson DW, Chong T, et al.: Apopain/ CPP2 cleaves proteins that are essential for cellular repair: fundamental principle of apoptotic death. J Exp Med 1996, 183:1957–1964.

    Article  PubMed  CAS  Google Scholar 

  35. Casiano CA, Martin SJ, Green DR, Tan EM: Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J Exp Med 1996, 184:765–770.

    Article  PubMed  CAS  Google Scholar 

  36. Rosen A, Casciola-Rosen L: Autoantigens as substrates for apoptotic proteases: implication for the pathogenesis of systemic autoimmune disease. Cell Death Differ 1999, 6:6–12.

    Article  PubMed  CAS  Google Scholar 

  37. Andrade F, Roy S, Nicholson D, Thornberry N, Rosen A, Casciola-Rosen L: Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTLinduced apoptosis. Immunity 1998, 8:451–460. This study demonstrates that many autoantigens are granzyme B substrates. Of particular interest is that granzyme B cleavage generates fragments that are unique compared with those generated during any other form of apoptosis. This suggests that CTL-induced apoptosis may generate novel fragments of autoantigens.

    Article  PubMed  CAS  Google Scholar 

  38. Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A: Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 1999, 190:815–825.This study demonstrates that most autoantigens targeted in systemic autoimmune diseases are cleaved by granzyme B during CTL-induced apoptosis. Coupled with the findings that granzyme B cleavage produces fragments unique to CTL-induced apoptosis, these data suggest that CTL-induced apoptosis may produce immunocryptic epitopes with the potential to break tolerance.

    Article  PubMed  CAS  Google Scholar 

  39. Utz PJ, Hottelet M, Schur PH, Anderson P: Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med 1997, 185:843–854.

    Article  PubMed  CAS  Google Scholar 

  40. Utz PJ, Hottelet M, Le TM, et al.: The 72-kDa component of signal recognition particle is cleaved during apoptosis. J Biol Chem 1998, 52:35362–35370.

    Article  Google Scholar 

  41. Albert ML, Sauter B, Bhardwaj N: Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998, 392:86–89. Dendritic cells exposed to apoptotic influenza-infected monocytes acquire antigen and can prime virus-specific CTL. This study demonstrates that apoptotic cells are immunogenic.

    Article  PubMed  CAS  Google Scholar 

  42. Albert ML, Pearce SFA, Francisco LM, et al.: Immature dendritic cells phagocytose apoptotic cells via aVb5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 1998, 188:1359–1368.This study demonstrates that "immature" (CD14-/CD83-) dendritic cells, but not "mature" (CD14-/CD83+) dendritic cells, phagocytize apoptotic cells and prime CTL with antigens acquired from apoptotic cells.

    Article  PubMed  CAS  Google Scholar 

  43. Rovere P, Sabbadini MG, Vallinoto C, et al.: Delayed clearance of apoptotic lymphoma cells allows cross-presentation of intracellular antigens by mature dendritic cells. J Leukocyte Biol 1999, 66:345–349.

    PubMed  CAS  Google Scholar 

  44. Hoffmann TK, Meidenbauer N, Dworacki G, Kanaya H, Whiteside TL: Generation of tumor-specific T lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells. Cancer Res 2000, 60:3542–3549.

    PubMed  CAS  Google Scholar 

  45. Mevorach D, Zhou JL, Song X, Elkon KB: Systemic exposure to irradiated apoptotic cells induces autoantibody production. Exp Med 1998, 188:387–392.

    Article  CAS  Google Scholar 

  46. Savill J, Fadok V: Corpse clearance defines the meaning of cell death. Nature 2000, 407:784–787.

    Article  PubMed  CAS  Google Scholar 

  47. Fadok VA, Bratton DL, Konowal A, et al.: Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/ paracrine mechanisms involving TGF-b, PGE2 and PAF. J Clin Invest 1998, 890–898. This study demonstrates that phagocytosis by macrophages is a noninflammatory process.

  48. Walport MJ, Davies KA, Morley BJ, Botto M: Complement deficiency and autoimmunity. Ann NY Acad Sci 1997, 815:267–285.

    Article  PubMed  CAS  Google Scholar 

  49. Korb LC, Ahearn JM: C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol 1997, 158:4525–4528. This study is the original observation that complement deficiency may cause SLE due to failed clearance of apoptotic cells.

    PubMed  CAS  Google Scholar 

  50. Navratil JS, Watkins SC, Wisnieski JJ, Ahearn JM: The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells. J Immunol 2001, 166:3231–3239. This study demonstrates that C1q specifically recognizes surface blebs on apoptotic cells, including vascular endothelial cells. Of particular interest is the finding that it is the globular head domains of the molecule that mediate this binding. This suggests that C1q may mediate recognition and phagocytosis of apoptotic cells via interactions with cells bearing receptors for the tail domains of the molecule, or through enzymatic activation of the classical pathway of complement, resulting in the deposition of C4- and C3-derived ligands on apoptotic cells.

    PubMed  CAS  Google Scholar 

  51. Botto M, Dell’Agnola C, Bygrave AE, et al.: Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nature Genet 1998, 19:56–59. These researchers demonstrate that apoptotic bodies accumulate in the glomeruli of C1q-deficient mice. This study suggests that C1q is involved in the recognition and clearance of apoptotic cells in vivo.

    Article  PubMed  CAS  Google Scholar 

  52. Taylor PR, Carugati A, Fadok VA, et al.: A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med 2000, 192:359–366. These researchers demonstrate that phagocytosis of apoptotic cells by macrophages is delayed in C1q-deficient mice. In addition, uptake of apoptotic cells is delayed in C4-deficient mice, but the defect is not as severe as that observed with C1q deficiency, suggesting that there may be a hierarchical requirement for complement proteins in phagocytic clearance of apoptotic cells.

    Article  PubMed  CAS  Google Scholar 

  53. Reid KB, Porter RR: Subunit composition and structure of subcomponent C1q of the first component of human complement. Biochem J 1976, 155:19–23.

    PubMed  CAS  Google Scholar 

  54. Nepomuceno RR, Tenner AJ: C1qRP, the C1q receptor that enhances phagocytosis, is detected specifically in human cells of myeloid lineage, endothelial cells and platelets. J Immunol 1998, 160:1929–1935. Expression of the C1q phagocytic receptor C1qRP was assessed on primary human cells and cell lines by RT PCR and by FACS analysis. C1qRP is expressed on endothelial cells, cells of myeloid origin, and platelets, but not on lymphocytes, epithelial cells, or fibroblasts.

    PubMed  CAS  Google Scholar 

  55. Klickstein LB, Barbashov SF, Liu T, Jack RM, Nicholson-Weller A: Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity 1997, 7:345–355.

    Article  PubMed  CAS  Google Scholar 

  56. Tas SW, Klickstein LB, Barbashov SF, Nicholson-Weller A: C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion. J Immunol 1999, 163:5056–5063.

    PubMed  CAS  Google Scholar 

  57. Navratil JS, Zurowski NB, Ahearn JM: Apoptotic endothelial cells and PBMC are tagged specifically by C3-and C4-derived ligands during membrane loss of RCA proteins: implications for immune tolerance and the pathogenesis of SLE. Immunopharmacology 2000, 49:36.

    Article  Google Scholar 

  58. Zurowski NB, Navratil JS, Ursu S, Nosce R, Ahearn JA: Ultraviolet B (UVB) induces apoptosis and deposition of C3- and C4- derived ligands on primary human and murine keratinocytes in vivo: implications for immune tolerance and the pathogenesis of SLE. Immunopharmacology 2000, 49:36.

    Article  Google Scholar 

  59. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N: Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000, 19:423–433. This study demonstrates that immature dendritic cells readily phagocytose apoptotic cells, but do not present the antigens thus acquired unless they receive maturation signals from inflammatory cytokines such as TNF-a and IFN-a. These data suggest that apoptosis occurring in an inflammatory environment may stimulate an immune response.

    Article  Google Scholar 

  60. Manfredi AA, Rovere P, Galati G, et al.: Apoptotic cell clearance in systemic lupus erythematosus. Opsonization by antiphospholipid antibodies. Arthritis Rheum 1998, 41:205–214.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Pittsburgh School of Medicine, University of Pittsburgh Arthritis Institute, S705 Biomedical Science Tower, 3500 Terrace Street, 15261, Pittsburgh, PA, USA

    Joseph M. Ahearn MD

Authors
  1. Jeannine S. Navratil MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph M. Ahearn MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Navratil, J.S., Ahearn, J.M. Apoptosis, clearance mechanisms, and the development of systemic lupus erythematosus. Curr Rheumatol Rep 3, 191–198 (2001). https://doi.org/10.1007/s11926-001-0018-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-001-0018-1

Keywords

Search

Navigation